Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D07SGS
|
||||
| Former ID |
DNC007114
|
||||
| Drug Name |
N-(4-(benzyloxy)phenethyl)pyridin-4-amine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528635] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H20N2O
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)COC2=CC=C(C=C2)CCNC3=CC=NC=C3
|
||||
| InChI |
1S/C20H20N2O/c1-2-4-18(5-3-1)16-23-20-8-6-17(7-9-20)10-15-22-19-11-13-21-14-12-19/h1-9,11-14H,10,15-16H2,(H,21,22)
|
||||
| InChIKey |
WPBRSJXCRWSAHJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [528635] | |
| Glutamate [NMDA] receptor subunit epsilon 2 | Target Info | Inhibitor | [528635] | ||
| KEGG Pathway | Ras signaling pathway | ||||
| Rap1 signaling pathway | |||||
| cAMP signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Circadian entrainment | |||||
| Long-term potentiation | |||||
| Glutamatergic synapse | |||||
| Dopaminergic synapse | |||||
| Alzheimer's disease | |||||
| Amyotrophic lateral sclerosis (ALS) | |||||
| Huntington's disease | |||||
| Cocaine addiction | |||||
| Amphetamine addiction | |||||
| Nicotine addiction | |||||
| Alcoholism | |||||
| Systemic lupus erythematosus | |||||
| Pathway Interaction Database | ErbB4 signaling events | ||||
| Reelin signaling pathway | |||||
| PathWhiz Pathway | Muscle/Heart Contraction | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.